BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, July 4, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 14, 2002
View Archived Issues
IGEN Wins $505M From Roche In Court; Roche Plans To Appeal
Read More
Same Gene Inflicts Both Axonal And Demyelinating Versions Of Charcot-Marie-Tooth Neuropathy
Read More
Antigenics Raises $60M From Shelf For Oncophage Trials
Read More
Novo Ends Deal With Flamel, Flamel Signs Deal With Servier
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Dendreon Falls On Provenge Phase III Interim Analysis Results
Poor interim statistical analysis of a Phase III trial of Provenge in prostate cancer patients caused Seattle-based Dendreon Corp.'s stock to dive Friday.
Read More
